Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Bladder Cancer (eBook)

Diagnosis and Clinical Management
eBook Download: EPUB
2015
John Wiley & Sons (Verlag)
978-1-118-67485-7 (ISBN)

Lese- und Medienproben

Bladder Cancer -
Systemvoraussetzungen
104,99 inkl. MwSt
(CHF 102,55)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen

Bladder Cancer: Diagnosis and Clinical Management is a 100% clinically-focused guide to bladder cancer, providing practical, modern and evidence-based guidance to the latest in diagnosis and management of the condition. It differs from other books in its complete clinical focus as opposed to a heavy analysis of pathogenesis or basic science.  As a result, practicing urologists and oncologists in the clinical setting will find it an essential resource to consult. 

In addition to the latest in diagnostic tools and imaging methods, core focus is on the management of each form of cancer at its various stages with up to date genomic data and targeted therapies.  Both drug therapies and the range of surgical options are covered, ensuring that this is the perfect tool for clinicians to consult when considering which type of management program is appropriate for each individual patient.  A key addition is the final section dedicated to optimizing health care delivery, featuring chapters on highly topical issues such as quality of life, patient advocacy and surgical education.

Full color throughout, and packed with excellent images, each chapter contains concise and didactic practical tips and tricks to enrich the reading experience, in addition to management algorithms and the very latest guidelines from the ASCO, AUA, ESMO and EAU concerning clinical management of bladder cancer.


Bladder Cancer: Diagnosis and Clinical Management is a 100% clinically-focused guide to bladder cancer, providing practical, modern and evidence-based guidance to the latest in diagnosis and management of the condition. It differs from other books in its complete clinical focus as opposed to a heavy analysis of pathogenesis or basic science. As a result, practicing urologists and oncologists in the clinical setting will find it an essential resource to consult. In addition to the latest in diagnostic tools and imaging methods, core focus is on the management of each form of cancer at its various stages with up to date genomic data and targeted therapies. Both drug therapies and the range of surgical options are covered, ensuring that this is the perfect tool for clinicians to consult when considering which type of management program is appropriate for each individual patient. A key addition is the final section dedicated to optimizing health care delivery, featuring chapters on highly topical issues such as quality of life, patient advocacy and surgical education. Full color throughout, and packed with excellent images, each chapter contains concise and didactic practical tips and tricks to enrich the reading experience, in addition to management algorithms and the very latest guidelines from the ASCO, AUA, ESMO and EAU concerning clinical management of bladder cancer.

Seth P. Lerner, Professor of Urology and Beth and Dave Swalm Chair in Urologic Oncology, Baylor College of Medicine, Houston, TX, USA Mark P. Schoenberg, MD, Professor and University Chair, The Department of Urology, The Montefiore Medical Center & The Albert Einstein College of Medicine, Bronx, NY USA Cora N. Sternberg, Chief, Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy and Adjunct Professor at La Sapienza University in Rome.

List of contributors


Hikmat Al-Ahmadie MD
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Andrea B. Apolo MD
Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA

Jessie L.S. Au PharmD, PhD
Chief Scientific Officer, Optimum Therapeutics, LLC, San Diego, CA, USA; Henry D & Ida Mosier Chair of Pharmaceutical Sciences, University of Oklahoma, Oklahoma City, OK, USA; Adjunct Professor of Surgery, Medical University of South Carolina, Charleston, SC, USA; Adjunct Professor of Medicine, Taipei Medical University, Taiwan; Distinguished University Professor Emeritus, The Ohio State University, Columbus, OH, USA

Dean F. Bajorin MD
Weill Cornell Medical College, New York, NY, USA

Rick Bangs MD, MS
BCAN, SWOG, and NCI Patient Advocate, Rochester Hills, MI, USA

Joaquim Bellmunt MD
Bladder Cancer Center, Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA, USA; University Hospital del Mar-IMIM, Barcelona, Spain

Laura A. Bertrand MD
Department of Urology, University of Iowa, Iowa City, IA, USA

Bernard H. Bochner MD
Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Lior Z. Braunstein MD
Harvard Radiation Oncology Program, Boston, MA, USA

Fabio Calabró MD
Department of Medical Oncology, San Camillo Forlanini Hospitals, Rome, Italy

Eugene K. Cha
Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Kevin Chan MD
Division of Urology and Urologic Oncology, City of Hope National Medical Center, Duarte, CA, USA

G. John Chen
Division of Health Services Research, University of Kansas School of Medicine, Kansas City, KS, USA

Guido Dalbagni MD
Attending Surgeon, Department of Urology, Memorial Sloan-Kettering Cancer Center, and Professor of Urology, Weill Cornell Medical College, New York, NY, USA

Siamak Daneshmand MD
USC Institute of Urology, USC/Norris Comprehensive Cancer Center, Los Angeles, CA, USA

Maria De Santis MD
Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna) and Applied Cancer Research – Institution for Translational Oncology Vienna (ACR-ITR VIEnna) – KFJ Hospital, Vienna, Austria

Scott Delacroix, Jr MD
Assistant Professor, Department of Urology, Louisiana State University School of Medicine, New Orleans, LA, USA

Colin P.N. Dinney MD
Professor, Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Jason A. Efstathiou MD
Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA

André P. Fay MD
Bladder Cancer Center, Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA, USA

Margit Fisch MD
Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Thomas W. Flaig MD
Department of Medicine, Division of Medical Oncology, University of Colorado Denver, and University of Colorado Cancer Center, Aurora, CO, USA

Georgios Gakis
Department of Urology, University Hospital Tübingen, Tübingen, Germany

Matthew D. Galsky MD
Associate Professor of Medicine; Director of Genitourinary Medical Oncology, Icahn School of Medicine at Mount Sinai, and The Tisch Cancer Institute, New York, NY, USA

Nilay M. Gandhi MD
James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA

J.M. Gaya MD
Department of Urological Oncology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain

Scott M. Gilbert MD MS
Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Heather Honoré Goltz
College of Public Service, University of Houston-Downtown, and Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, USA

John L. Gore
Department of Urology, University of Washington, Seattle, WA, USA

Ahmed Haddad MD
Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX, USA

Noah M. Hahn MD
Associate Professor of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA

Donna E. Hansel MD, PhD
Professor, Department of Pathology; Chief, Division of Anatomic Pathology, University of California, San Diego, La Jolla, CA, USA

Harry W. Herr MD
Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Gopa Iyer MD
Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Nicholas D. James MBBS, PhD
School of Cancer Sciences, University of Birmingham, Birmingham, UK

George J.S. Kallingal MD, MPH
Clinical Instructor, Department of Urology, University of Miami, Miami, FL, USA

Ashish M. Kamat MD
Associate Professor, Department of Urology, MD Anderson Cancer Center, Houston, TX, USA

Mark Kawachi MD
Division of Urology and Urologic Oncology, City of Hope National Medical Center, Duarte, CA, USA

Jaegil Kim MD
Broad Institute of Harvard and MIT, Cambridge, MA, USA

William Y. Kim MD
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Tobias Klatte
Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

Badrinath Konety
Department of Urology, University of Minnesota, Minneapolis, MN, USA

Theresa Koppie
Department of Urology, University Hospital Tübingen, Tübingen, Germany

Marc A. Kowalkowski
Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA

David J. Kwiatkowski MD
Broad Institute of Harvard and MIT, Cambridge, MA, USA and Brigham and Women’s Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Donald L. Lamm MD
Clinical Professor, University of Arizona; Director, BCG Oncology, Phoenix, AZ, USA

David M. Latini PhD
Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA

Nathan Lawrentschuk MD
University of Melbourne, Department of Surgery; Olivia Newton-John Cancer Research Institute, Austin Hospital and Peter MacCallum Cancer Centre, Division of Cancer Surgery, Melbourne, Australia

Cheryl T. Lee MD
Department of Urology, University of Michigan, Ann Arbor, MI, USA

Seth P. Lerner MD, FACS
Department of Urology, Baylor College of Medicine, Houston, TX, USA

Jeffrey J. Leow MD
Center for Surgery and Public Health, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA; Department of Urology, Tan Tock Seng Hospital, Singapore

Joseph C. Liao
Department of Urology, Stanford University School of Medicine, Stanford, CA, USA

Fredrik Liedberg MD
Department of Urology, Lund University, Malmö, Sweden

Jen-Jane Liu
Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA

Yair Lotan MD
Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX, USA

David J. McConkey MD
Departments of Urology and Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Edward M. Messing MD, FACS
W.W. Scott Professor and Chairman, Department of Urology, University of Rochester, School of Medicine and Dentistry, Rochester, New York, USA

Matthew I. Milowsky MD
Department of Medicine, Division of Hematology/Oncology, University of North Carolina at Chapel Hill, and Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA

Nihal E. Mohamed
Department of Urology and Oncological Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Andreas Neisius MD
Department of Urology, University Medical Center, Johannes Gutenberg University, Mainz, Germany

Matthew Nielsen MD, MS
Assistant Professor, Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Michael A. O’Donnell MD
Professor and Director of Urologic Oncology, Department of Urology, University of Iowa, Iowa City, IA, USA

Peter H....

Erscheint lt. Verlag 4.8.2015
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Medizinische Fachgebiete Urologie
Schlagworte bladder cancer • bladder tumours • Cancer • Chirurgie u. chirurgische Spezialgebiete • Medical Science • Medizin • Oncology & Radiotherapy • Onkologie u. Strahlentherapie • Surgery & Surgical Specialities • urologic cancer • Urologic oncology • Urologie • Urology
ISBN-10 1-118-67485-5 / 1118674855
ISBN-13 978-1-118-67485-7 / 9781118674857
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
EPUBEPUB (Adobe DRM)

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich